Uterine sarcoma, version 1.2016: Featured updates to the NCCN Guidelines

Wui Jin Koh, Benjamin E. Greer, Nadeem R. Abu-Rustum, Sachin M. Apte, Susana M. Campos, Kathleen R. Cho, Christina Chu, David Cohn, Marta Ann Crispens, Don S. Dizon, Oliver Dorigo, Patricia J. Eifel, Christine M. Fisher, Peter Frederick, David K. Gaffney, Suzanne George, Ernest Han, Susan Higgins, Warner K. Huh, John R. LurainAndrea Mariani, David Mutch, Amanda Nickles Fader, Steven W. Remmenga, R. Kevin Reynolds, Todd Tillmanns, Fidel A. Valea, Catheryn M. Yashar, Nicole R. McMillian, Jillian L. Scavone

Research output: Contribution to journalReview articlepeer-review

51 Scopus citations

Abstract

The NCCN Guidelines for Uterine Neoplasms provide interdisciplinary recommendations for treating endometrial carcinoma and uterine sarcomas. These NCCN Guidelines Insights summarize the NCCN Uterine Neoplasms Panel's 2016 discussions and major guideline updates for treating uterine sarcomas. During this most recent update, the panel updated the mesenchymal tumor classification to correspond with recent updates to the WHO tumor classification system. Additionally, the panel revised its systemic therapy recommendations to reflect new data and collective clinical experience. These NCCN Guidelines Insights elaborate on the rationale behind these recent changes.

Original languageEnglish (US)
Pages (from-to)1321-1331
Number of pages11
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume13
Issue number11
DOIs
StatePublished - Nov 1 2015

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Uterine sarcoma, version 1.2016: Featured updates to the NCCN Guidelines'. Together they form a unique fingerprint.

Cite this